CME Group Reports Strong Q3 2022 Financial Performance

CME Group, the world's leading derivatives marketplace, has today unveiled its strong financial results for the third quarter of 2022 (Q3 2022), which was driven by a surge in trading volume.

Specifically, the group revenue during the quarter came in at $1.2 billion, compared to that of last same period at $1.1 billion. Net income was $680 million, decreasing from $926 million in Q3 2021. And diluted earnings per share was $1.87, falling from $2.58 in last Q3.

Fazzaco Hall of Fame 2022 Officially Opens (Click to Nominate)!​

On a adjusted basis, net income and diluted earnings per share stood at $719 million and $1.98, up 25% and 24% on a yearly basis, respectively.

Average daily volume (ADV) during Q3 2022 came in at 22.4 million contracts.

"Our strong Q3 financial performance was driven by a 26% increase in trading volume, generating double-digit growth in total revenue," said CME Group Chairman and Chief Executive Officer Terry Duffy. "During the quarter, year-over-year volume rose in five of our six asset classes, led by interest rates, equity indexes and a near-record quarter for foreign exchange. Likewise, the demand for our products remains strong, with year-to-date volumes up 22%, as clients continue to manage risk amid global economic and geopolitical uncertainty."